AGN
Market cap | $63.36 Billion |
---|---|
Enterprise Value | - |
Dividend Yield | $2.96 (-%) |
Earnings per Share | $-7.58 |
Beta | - |
Outstanding Shares | 328,277,000 |
Avg 30 Day Volume | 4,635,647 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | - |
---|---|
PEG | - |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | - |
Enterprise Value to EBIT | - |
Enterprise Value to Net Income | - |
Total Debt to Enterprise | - |
Debt to Equity | - |
No data
No data
Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized T...